Show simple item record

dc.creatorSchwartz, Robert J.
dc.creatorPotaman, Vladimir N.
dc.creatorIslas, Jose Francisco
dc.date.accessioned2019-06-17T17:07:38Z
dc.date.available2019-06-17T17:07:38Z
dc.date.issued2013-07-16
dc.identifier.urihttps://hdl.handle.net/1969.1/177036
dc.description.abstractA method for modulating cell differentiation capabilities using heterologous gene expression. Some embodiments of the invention relate to a method for inducing a cardiac progenitor cell by delivering a reprogramming factor to the cell, wherein the reprogramming factor comprises ETS2 or a combination of ETS2 and Mesp1.en
dc.languageeng
dc.publisherUnited States. Patent and Trademark Office
dc.rightsPublic Domain (No copyright - United States)en
dc.rights.urihttp://rightsstatements.org/vocab/NoC-US/1.0/
dc.titleETS2 and MESP1 generate cardiac progenitors from fibroblastsen
dc.typeUtility patenten
dc.format.digitalOriginreformatted digitalen
dc.description.countryUS
dc.contributor.assigneeUniversity of Houston
dc.contributor.assigneeTexas Heart Institute
dc.contributor.assigneeThe Texas A&M University System
dc.identifier.patentapplicationnumber13/040611
dc.subject.uspcprimary435/455
dc.subject.uspcother435/6.13
dc.subject.uspcother435/363
dc.subject.uspcother435/371
dc.subject.uspcother435/465
dc.subject.uspcother435/467
dc.subject.uspcother435/476
dc.date.filed2011-03-04
dc.publisher.digitalTexas A&M University. Libraries
dc.subject.cpcprimaryC12N 5/0696
dc.subject.cpcprimaryC12N 15/85
dc.subject.cpcprimaryC12N 5/0657
dc.subject.cpcprimaryC12N 2501/60
dc.subject.cpcprimaryC12N 2506/1307
dc.subject.cpcprimaryC12N 2510/00
dc.subject.cpcprimaryC12N 2501/40


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record